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Abstract
Dermatofibrosarcomaprotuberans is a rare, soft tissue
tumour with high rate of recurrence. It is locally
aggressive, with a low rate of metastasis. We describe the
case of a 42 year old man who presented with a re-
recurrent, large tumour situated on the anterior chest wall
in the sternal region. We did a wide local excision and
covered the resulting defect by using bilateral, pectoralis
major myocutaneous flaps. Histopathology and
immunohistochemical staining findings were consistent
with the diagnosis of Dermatofibrosarcoma
Protuberance. Post operatively the patient was treated
with chemotherapy and radiotherapy.
Keywords: Dermatofibrosarcomaprotuberans, Chest
wall, Soft tissue tumour.
Introduction
Dermatofibrosarcomaprotuberans (DFSP) is an
uncommon soft tissue tumour that tends to recur. It is a
locally aggressive neoplasmwith a high rate of recurrence
despite rarely metastasising. It most commonly occurs on
the trunk (42-72%), followed by the proximal extremities
(16-30%) and rarely occurs above the neck (10-16%).1
DFSP comprises of 6% of all soft tissue sarcomas and less
than 0.1% of all cutaneous malignancies.2 The incidence
rate is estimated to be at 0.8 cases per million persons per
year.2 We describe the case of a 42 year old male that
presented with re-recurrent DFSP of the chest wall.
Case Report
A 42 year old man came to the hospital with a painless
mass in the sternal region since 4-5 years. He had a past
history of a similar mass twice before, once in 2003 and
then in 2008, both times the mass was excised in other
centers. A histological biopsy taken in 2008 did not reveal
DFSP. The patient had lost both previous surgery and
biopsy records. During our physical exam we found the
mass to belobulated, non tender, firm, mobile
horizontally, 5.5 x 4cm in size, with well definedmargins, a
shiny surface and a previous surgery scar. There was no
cervical or axillary lymphadenopathy and the rest of the
physical exam was within normal limits. CT scan report
revealed two closely applied oval shaped soft-tissue
density enhancing masses located on the anterior aspect
of the chest wall at the level of the manubrium. One
lobule measured about 5.4 x 3.9cm and the other one
measured about 5.3 x 4.5cm with no regional
lymphadenopathy. Multiple hypodense areas in the
center of these lesions suggestive of necrosis were noted.
Wide local excision with a grossly 3cm tumour freemargin
all around was done. Bilateral, pectoralis
majormyocutaneous flaps were used to cover the defect
resulting from the excision. Biopsy revealed
Dermatofibrosarcomaprotuberans. It also showed the
lesion to be less than 1cm from the closest peripheral and
0.2cm from the deep margin of resection. Mitotic count
ranges were from 6 to 8/10 HPF with few areas showing
up to 10 mitosis/10 HPF. Mib-1 (Ki-67) index was
approximately 15-20%. Immunohistochemical staining
was diffusely positive for CD34 and negative for CD117.
Post operatively the upper 4cm part of the wound
became infected. This was treated by antibiotics and
dressing. Medical and radiation oncologists were
consulted, who after discussion in the tumour board
decided to give post operative chemotherapy due to brisk
mitotic activity and also radiation therapy because of the
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Figure-1: Dermatofibrosarcoma Protuberans of the anterior chest wall.
close margin. The patient received six cycles of
chemotherapy with Ifosfomide, mesna and Doxorubicin,
all of which were tolerated well. After completion of
chemotherapy, repeated staging workup did not show
any evidence of disease at both local and distant sites.
Later the patient completed 60 G of radiotherapy to the
sternum uneventfully. Currently the patient is in complete
remission for 21 months till date and he is in regular
follow up every three months.
Discussion
Chest wall tumours make up less than 5% of thoracic
malignancies.3 Among primary malignant chest wall
tumours, soft tissue sarcomas constitute 50% of them.
DFSP was initially reported in literature as early as 1890,
but it was first described in 1924 by Darier and Ferrand as
a distinct cutaneous disease entity called progressive and
recurring dermatofibroma.1 Hoffman termed it DFSP in
1925. The origin of DFSP are still unclear but a genetic
defect is present in 95% of cases due to either a
translocation of chromosomes 17 and 22, or the
formation of a ring.4 DFSP is slightly more common in
males and is seen most often in adult life.4
Initially the tumour starts off as a small papule or non-
indurated patch, that is often ignored. This progresses to a
single, raised, red to blue, firm cutaneous nodule.5 It
further progresses to a painless, cutaneous,
multilobulated mass, which is the most often
encountered finding on presentation, also in our case. The
initial lesion of DFSP can sometimes be mistaken for a
keloid due to the similarity in appearance, therefore
prompt diagnosis is vital for the treatment of this
malignant tumour. Due to its local aggressivevess, it can
grow into the surrounding fat, fascia, muscle and even
bone. Rarely, distant metastasis is seen in upto 4-6% of
patients, with the lungs being the most common site,1,6
no metastasis was found in our patient. DFSP
characteristically has a high rate of recurrence, varying in
the literature from 10-80%.7 Histologically it is identified
by a pattern of monomorphous proliferation of
cystological bland spindle cells with a visible storiform or
whorled architecture.7 CD34 antigen is a very common
finding and its expression aids the diagnosis of DFSP.8
Among the various treatment modalities, surgery is the
mainstay of treatment by wide excision with a safety
margin of 3cm, including the underlying fascia since
emphasis is on histological free margins for local control.9
Conventional chemotherapy is not commonly used to
treat DFSP. Radiation therapy (RT) may be recommended
if adequate wide excision may result in major cosmetic
defect or if the tumourmargins are positive. Postoperative
adjuvant RT may reduce the risk of recurrence when clear
surgical margins are equivocal,10 hence this was utilized in
our case. Mohs surgery, a microscopic surgical technique,
is widely gaining acceptance as the treatment of choice
due its high oncological effectiveness and maximal tissue
salvage. Imatinib, a tyrosine kinase inhibitorcan be used
for the treatment of adult patients with unresectable,
recurrent, and metastatic DFSP. Overall, the most
significant prognostic factor in patients with DFSP has
proved to be the extent of surgical resection, especially
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Figure-2: Preoperative CT scan of the chest showing the lobulated tumour in the
sternal region.
Figure-3: Wide local excision of the of the tumour.
the success of the initial surgical excision having a
significant effect on the outcome.8
Conclusion
As dermatofibrosarcoma is a locally aggressive neoplasm
with high rate of recurrence, wide local excision with at
least 3cms tumour free margin at the time of first surgery
and oncologists consultation will prevent recurrence.
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